ROSEN, STILLED INVESTOR COUNSEL, Encourages RTX Corporation f/k/a Raytheon Technologies Corporation Investors to Inquire About Securities Class Action Investigation – RTX
August 02, 2023 11:48 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of RTX...
Bragar Eagel & Squire, P.C. Is Investigating Veradigm and RTX and Encourages Investors to Contact the Firm
July 31, 2023 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Veradigm, Inc. (NASDAQ:...
RTX CORP. INVESTOR ALERT: Kaplan Fox Investigates Potential Securities Fraud at RTX Corporation
July 26, 2023 18:49 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, July 26, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of RTX Corp. f/k/a Raytheon Technologies Corp. (“RTX”...
RTX Corporation Investigation Alert: Johnson Fistel, LLP Encourages Investors to Submit Their Information Below
July 25, 2023 15:11 ET
|
Johnson Fistel, LLP
SAN DIEGO, July 25, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether RTX Corporation ("RTX" or the “Company”) (NYSE: RTX),...
Sorrento Therapeutics Completes Enrollment of Phase 2 Clinical Trial of Resiniferatoxin (RTX) for Treatment of Knee Pain in Moderate to Severe Osteoarthritis of the Knee (OAK) Patients
September 26, 2022 09:00 ET
|
Sorrento Therapeutics, Inc.
Phase 2 trial of RTX for OAK pain completed enrollment with last patient (n=120) dosedNo limiting toxicities have been encountered during the trial to date. Patients are now being monitored for...
RAYTHEON ALERT: Bragar Eagel & Squire, P.C. is Investigating Raytheon Technologies Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
December 17, 2021 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Dec. 17, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Raytheon Technologies...
FDA Clears Sorrento Phase 2 Trial Of Non-Opioid Product Candidate Resiniferatoxin (RTX) For Treatment of the Knee Pain in Osteoarthritis (OA) Patients
July 06, 2021 14:34 ET
|
Sorrento Therapeutics, Inc.
Phase 2 trial of RTX for OA pain to proceed following FDA clearance.Phase 1b data demonstrated RTX safety for a single intra-articular administration without dose limiting toxicity (DLT) at any doses...
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Sequential Brands and Raytheon on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
January 22, 2021 20:00 ET
|
Bragar Eagel & Squire
NEW YORK, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors of Sequential Brands...
FINAL DEADLINE TUESDAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Reminds Raytheon Technologies Corporation f/k/a Raytheon Company Investors of Important December 29 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – RTX, RTN
December 24, 2020 16:12 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 24, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Raytheon Technologies Corporation f/k/a Raytheon Company (NYSE:...
ROSEN, TRUSTED INVESTOR COUNSEL, Reminds Raytheon Technologies Corporation f/k/a Raytheon Company Investors of Important Deadline in Securities Class Action First Filed by the Firm; Encourages Investors with Losses in Excess of $100K to Contact Firm – RTX, RTN
December 15, 2020 16:08 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Raytheon Technologies Corporation f/k/a Raytheon Company (NYSE:...